162 related articles for article (PubMed ID: 21216724)
1. Novel medical treatment of pituitary adrenocorticotropic hormone-dependent hypercortisolism: a case study.
Vlad LD; Alzahrani SA
Endocr Pract; 2010; 16(6):1073-4. PubMed ID: 21216724
[No Abstract] [Full Text] [Related]
2. Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6).
Correa-Silva SR; Nascif SO; Molica P; Sá LB; Vieira JG; Lengyel AM
Clin Endocrinol (Oxf); 2010 Jan; 72(1):70-5. PubMed ID: 19453623
[TBL] [Abstract][Full Text] [Related]
3. Cushing's disease: adrenal steroidogenesis inhibitors.
Pivonello R; Simeoli C; Di Paola N; Colao A
Pituitary; 2022 Oct; 25(5):726-732. PubMed ID: 36036308
[TBL] [Abstract][Full Text] [Related]
4. What is the role of medical therapy in adrenal-dependent Cushing's syndrome?
Braun LT; Reincke M
Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101376. PubMed ID: 32063487
[TBL] [Abstract][Full Text] [Related]
5. Updates in adrenal steroidogenesis inhibitors for Cushing's syndrome - A practical guide.
Varlamov EV; Han AJ; Fleseriu M
Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101490. PubMed ID: 33707082
[TBL] [Abstract][Full Text] [Related]
6. PPAR-gamma in Cushing's disease.
Heaney AP
Pituitary; 2004; 7(4):265-9. PubMed ID: 16416039
[TBL] [Abstract][Full Text] [Related]
7. Metyrapone is useful only as adjunctive therapy in Cushing's disease.
Orth DN
Ann Intern Med; 1978 Jul; 89(1):128-30. PubMed ID: 208445
[No Abstract] [Full Text] [Related]
8. Medical Management of Cushing Disease.
Tritos NA; Biller BMK
Neurosurg Clin N Am; 2019 Oct; 30(4):499-508. PubMed ID: 31471057
[TBL] [Abstract][Full Text] [Related]
9. New prospects for drug treatment in Cushing disease.
Barahona Constanzo MJ; del Pozo Picó C
Endocrinol Nutr; 2012 Dec; 59(10):599-605. PubMed ID: 23036936
[TBL] [Abstract][Full Text] [Related]
10. Prolonged remission in florid Cushing's syndrome following metyrapone treatment.
Beardwell CG; Adamson AR; Shalet SM
Clin Endocrinol (Oxf); 1981 May; 14(5):485-92. PubMed ID: 6273022
[TBL] [Abstract][Full Text] [Related]
11. A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing's syndrome.
Reincke M; Ritzel K; Oßwald A; Berr C; Stalla G; Hallfeldt K; Reisch N; Schopohl J; Beuschlein F
Eur J Endocrinol; 2015 Oct; 173(4):M23-32. PubMed ID: 25994948
[TBL] [Abstract][Full Text] [Related]
12. Factitious ACTH-dependent, apparent hypercortisolism: The problem with late-night salivary cortisol measurements collected at home.
Kline GA; Buse JD; Van Der Gugten JG; Holmes DT; Chin AC; Sadrzadeh SMH
Clin Endocrinol (Oxf); 2017 Dec; 87(6):882-885. PubMed ID: 28929506
[No Abstract] [Full Text] [Related]
13. A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule.
Timmers HJ; van Ginneken EM; Wesseling P; Sweep CG; Hermus AR
J Endocrinol Invest; 2006 Nov; 29(10):934-9. PubMed ID: 17185905
[TBL] [Abstract][Full Text] [Related]
14. Effect of one month ketoconazole treatment on GH, cortisol and ACTH release after ghrelin, GHRP-6 and GHRH administration in patients with Cushing's disease.
Correa-Silva SR; Nascif SO; Silva MR; Molica P; Lengyel AM
Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1110-7. PubMed ID: 18157387
[TBL] [Abstract][Full Text] [Related]
15. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
[TBL] [Abstract][Full Text] [Related]
16. Cushing's disease in a patient with a 'nonfunctioning' pituitary tumor. Spontaneous development and remission.
Gogel EL; Salber PR; Tyrrell JB; Rosenblum ML; Findling JW
Arch Intern Med; 1983 May; 143(5):1040-2. PubMed ID: 6089681
[TBL] [Abstract][Full Text] [Related]
17. Cushing syndrome due to ectopic adrenocorticotropic hormone secretion in a 3-year-old child.
Matarazzo P; Tuli G; Tessaris D; Verna F; Rabbone I; Lezo A; Brunati A; Salizzoni M; Carbonaro G; Terzolo M; Reimondo G; Papotti M; Lala R
J Pediatr Endocrinol Metab; 2011; 24(3-4):219-22. PubMed ID: 21648297
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas.
Cannavò S; Almoto B; Dall'Asta C; Corsello S; Lovicu RM; De Menis E; Trimarchi F; Ambrosi B
Eur J Endocrinol; 2003 Sep; 149(3):195-200. PubMed ID: 12943521
[TBL] [Abstract][Full Text] [Related]
19. Crooke's Changes In Cushing's Syndrome Depends on Degree of Hypercortisolism and Individual Susceptibility.
Oldfield EH; Vance ML; Louis RG; Pledger CL; Jane JA; Lopes MB
J Clin Endocrinol Metab; 2015 Aug; 100(8):3165-71. PubMed ID: 26147609
[TBL] [Abstract][Full Text] [Related]
20. Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole.
Feelders RA; Hofland LJ; de Herder WW
Neuroendocrinology; 2010; 92 Suppl 1():111-5. PubMed ID: 20829630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
